Table A3.
Abbreviations
| Acronym | Definition |
|---|---|
| ABG | arterial blood gas |
| ACC | American College of Cardiology |
| ACTH | adrenocorticotropic hormone |
| ADL | activities of daily living |
| AE | adverse event |
| AHA | acquired hemophilia A |
| AHA | American Heart Association |
| AI | adrenal insufficiency |
| ALT | alanine aminotransferase |
| ANA | antinuclear antibodies |
| ANCA | antineutrophil cytoplasmic antibodies |
| ANNA-1 | anti-neuronal nuclear antibody 1 |
| APTT | activated partial thromboplastic time |
| ASCO | American Society of Clinical Oncology |
| ASH | American Society of Hematology |
| ASMA | anti-smooth muscle antibodies |
| AST | aspartate aminotransferase |
| ATG | antithymocyte globulin |
| BAL | bronchoalveolar lavage |
| BNP | brain natriuretic peptide |
| BSA | body surface area |
| CAR-T | chimeric antigen receptor T-cell |
| CBC | complete blood count |
| CMP | comprehensive metabolic panel |
| CMV | cytomegalovirus |
| CNS | central nervous system |
| CPK | creatine phosphokinsase |
| CRP | C-reactive protein |
| CSF | cerebrospinal fluid |
| CT | computed tomography |
| CTCAE | Common Terminology Criteria for Adverse Events |
| CTLA-4 | cytotoxic T-cell lymphocyte-4 |
| CTPA | computed tomographic pulmonary angiography |
| CXR | chest x-ray |
| DAT | direct antiglobulin test |
| DIC | disseminated intravascular coagulation |
| DEB | diepoxybutane |
| DKA | diabetic ketoacidosis |
| DM | diabetes mellitus |
| DVT | deep vein thrombosis |
| EBV | Epstein-Barr virus |
| EEG | electroencephalogram |
| EGD | esophagogastroduodenoscopy |
| EMG | electromyography |
| EMS | emergency medical services |
| ENT | ears, nose, and throat |
| ESR | erythrocyte sedimentation rate |
| FLAIR | fluid-attenuated inversion recovery |
| FSH | follicle-stimulating hormone |
| FT4 | free thyroxine |
| G1 | grade 1 |
| G2 | grade 2 |
| G3 | grade 3 |
| G4 | grade 4 |
| GBS | Guillain-Barré syndrome |
| GCSF | granulocyte colony-stimulating factor |
| GI | gastrointestinal |
| GPI | glycosylphosphatidylinositol |
| HCV | hepatitis C virus |
| Hgb | hemoglobin |
| HHV6 | human herpesvirus 6 |
| HIV | human immunodeficiency virus |
| HRCT | high-resolution computed tomography |
| HSV | herpes simplex virus |
| HUS | hemolytic uremic syndrome |
| IA | inflammatory arthritis (continued in next column) |
| ICPi | mmune checkpoint inhibitor |
| ICU | intensive care unit |
| igG | mmunogloblulin G |
| irAE | immune-related adverse event |
| ITP | diopathic thrombocytopenic purpura |
| IV | intravenous |
| IVIG | ntravenous immunoglobulin |
| LEMS | Lambert-Eaton Myasthenic Syndrome |
| LFTs | iver function tests |
| LH | utenizing hormone |
| LLN | ower limit of normal |
| LMWH | ow molecular weight heparin |
| MCV | mean corpuscular volume |
| MDS | myelodysplastic syndromes |
| MGFA | myasthenia gravis foundation of America |
| MMF | mycophenolate mofetil |
| MRI | magnetic resonance imaging |
| NCS | nerve conduction study |
| NIF | negative inspiratory force |
| O&P | ova and parasite |
| PCP | Pneumocystis pneumonia |
| PCR | polymerase chain reaction |
| PD-1 | programmed death 1 |
| PD-L1 | programmed death ligand 1 |
| PE | pulmonary embolism |
| PEX | plasma exchange |
| PMNs | polymorphonuclear cells |
| PNH | paroxysmal nocturnal hemoglobinuria |
| PPI | proton pump inhibitor |
| PT | prothrombin time |
| PTU | propylthiouracil |
| RBC | red blood cell |
| RPR | rapid plasma reagin |
| T1DM | type 1 diabetes mellitus |
| T2DM | type 2 diabetes mellitus |
| TB | tuberculosis |
| TID | three times a day |
| TPO | thyroid peroxidase |
| TSH | thyroid stimulating hormone |
| TSI | thyroid stimulation immunoglobulin |
| TTE | transthoracic echocardiogram |
| TTP | thrombotic thrombocytopenic purpura |
| ULN | upper limit of normal |
| US | ultrasound |
| UTIs | urinary tract infections |
| V/Q | ventilation-perfusion lung scan |
| VC | vital capacity |
| VKA | vitamin K antagonists |
| VTE | venous thromboembolism |
| WBC | white blood cell |